Integrated Diagnostics Holdings (IDH) significantly expands its foothold in the Middle East by acquiring an additional 49% stake in Biolab KSA, capitalizing on the growing demand for diagnostic services.

Target Overview

Integrated Diagnostics Holdings plc (IDH) is a preeminent provider of diagnostic services operating across several regions, including Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The company has demonstrated remarkable financial performance, recording substantial revenue growth of 42% in the first half of 2025, alongside improving profit margins, indicating a strong operational framework and market position.

IDH's subsidiary in Egypt, Al Borg Scan, has recently made notable advancements in the radiology sector, highlighting the company's commitment to enhancing its service portfolio. The continuous expansion of services, particularly in radiotherapy, positions IDH as a comprehensive diagnostics solutions provider aiming for operational excellence.

Industry Overview in Egypt

The healthcare and diagnostic services sector in Egypt is witnessing robust growth, driven by increased health awareness and a rising demand for quality healthcare services. T